Drug:
Reaction: ERYTHEMA
20250101 - 20251231
No. 701 - 800
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
701 | 25053935 |
US |
24 | 2 |
Dry skin, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
702 | 25054085 |
US |
3 | 2 |
Dermatitis atopic, Rash, Erythema, |
||||
DUPILUMAB, |
||||
703 | 25054087 |
US |
58 | 2 |
Erythema, Pruritus, Skin burning sensation, |
||||
DUPILUMAB, DUPILUMAB, LOSARTAN, |
||||
704 | 25054112 |
US |
18 | 1 |
Pruritus, Skin exfoliation, Erythema, Eye irritation, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
705 | 25054165 |
US |
2 | 1 |
Eczema, Erythema, Pruritus, Exfoliative rash, |
||||
DUPILUMAB, HYDROXYZINE, |
||||
706 | 25054167 |
US |
41 | 2 |
Eczema, Erythema, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
707 | 25054257 |
US |
22 | 1 |
Eczema, Erythema, Pruritus, Feeling hot, |
||||
DUPILUMAB, DUPILUMAB, |
||||
708 | 25054282 |
US |
48 | 2 |
Erythema, Pruritus, Skin burning sensation, Condition aggravated, |
||||
DUPILUMAB, |
||||
709 | 25054288 |
US |
2 | |
Eye disorder, Erythema, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
710 | 25054303 |
US |
81 | 2 |
Erythema, |
||||
DUPILUMAB, |
||||
711 | 25054424 |
US |
41 | 2 |
Alopecia, Swelling, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
712 | 25054441 |
US |
1 | |
Erythema, |
||||
DUPILUMAB, |
||||
713 | 25054483 |
US |
13 | |
Erythema, Oral herpes, |
||||
DUPILUMAB, |
||||
714 | 25054503 |
GB |
59 | |
Erythema, Rash pruritic, Acarodermatitis, Blister, |
||||
OCRELIZUMAB, BACLOFEN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
715 | 25059705 |
28 | 2 | |
Erythema, Erythema, Maternal exposure during pregnancy, |
||||
AMPICILLIN, AMPICILLIN SODIUM, AMPICILLIN INJECTION, |
||||
716 | 25043436 |
US |
92 | 2 |
Erythema, Pruritus, Blood pressure increased, |
||||
DALBAVANCIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, APIXABAN, LISINOPRIL, METOPROLOL TARTRATE, METOPROLOL, |
||||
717 | 25043524 |
US |
1 | |
Off label use, Pruritus, Erythema, Urticaria, |
||||
OMALIZUMAB, |
||||
718 | 25043587 |
JP |
8 | |
Intestinal perforation, Rash, Erythema, Nausea, |
||||
OSIMERTINIB, OSIMERTINIB, CISPLATIN, PEMETREXED, PEMETREXED DISODIUM, |
||||
719 | 25043589 |
US |
73 | 1 |
Discomfort, Burning sensation, Erythema, Musculoskeletal discomfort, Musculoskeletal stiffness, Flushing, Vertigo, Palpitations, |
||||
DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, |
||||
720 | 25043689 |
CA |
54 | 2 |
Blood pressure increased, Inappropriate schedule of product administration, Upper limb fracture, Paraesthesia oral, Urticaria, Erythema, Diarrhoea, Uterine neoplasm, |
||||
DAPAGLIFLOZIN, SACUBITRIL AND VALSARTAN, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, SPIRONOLACTONE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, BISOPROLOL FUMARATE, |
||||
721 | 25043860 |
CA |
24 | 2 |
Erythema, Pruritus, Hypersensitivity, Sensitivity to weather change, Urticaria, Allergy to chemicals, Eye swelling, Inappropriate schedule of product administration, Lip swelling, Product dose omission issue, Weight increased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, PREDNISONE, |
||||
722 | 25043892 |
CA |
64 | 1 |
Anaphylactic reaction, Erythema, Urticaria, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, MONTELUKAST, |
||||
723 | 25043904 |
CA |
71 | 1 |
Eczema nummular, Dermatitis atopic, Dermatitis contact, Drug eruption, Eczema, Erythema, Pityriasis, Pruritus, Rash maculo-papular, Skin exfoliation, |
||||
724 | 25043916 |
US |
33 | 2 |
Illness, Erythema, |
||||
NATALIZUMAB, NATALIZUMAB, |
||||
725 | 25043992 |
JP |
86 | 1 |
Cytokine release syndrome, C-reactive protein increased, Pyrexia, Blood potassium decreased, Swelling, Procalcitonin abnormal, Erythema, Blood sodium decreased, Hepatic function abnormal, Adrenal disorder, |
||||
PEMBROLIZUMAB, ENFORTUMAB VEDOTIN, |
||||
726 | 25044111 |
CA |
71 | 2 |
Angioedema, Arthralgia, Back pain, Blood pressure systolic increased, Chronic spontaneous urticaria, Eczema, Erythema, Fibromyalgia, Hypertension, Inappropriate schedule of product administration, Inflammation, Lichenification, Obstructive airways disorder, Pruritus, Rheumatoid arthritis, Scratch, Skin abrasion, Skin warm, Swelling, Swelling face, Tinnitus, Urticaria, Therapeutic response decreased, Off label use, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DOXEPIN, DOXEPIN HYDROCHLORIDE, DOXEPIN, DOXEPIN HYDROCHLORIDE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, MONTELUKAST SODIUM, MONTELUKAST SODIUM, MONTELUKAST SODIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
727 | 25044203 |
GR |
75 | 2 |
Abdominal discomfort, Macule, Erythema, |
||||
CINNAMOMUM, ECHINACEA (ANGUSTIFOLIA), HYDRASTIS CANADENSIS, LAPPA MAJOR, TRIFOLIUM PRATENSE, VALACYCLOVIR HYDROCHLORIDE, APIXABAN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
728 | 25044253 |
HR |
33 | 1 |
Topical steroid withdrawal reaction, Pruritus, Wound, Poor quality sleep, Erythema, Dermatitis, Temperature regulation disorder, Product prescribing issue, |
||||
MOMETASONE FUROATE, MOMETASONE, |
||||
729 | 25044271 |
BR |
2 | |
Drug hypersensitivity, Blister, Contusion, Erythema, Pruritus, |
||||
DEXLANSOPRAZOLE, |
||||
730 | 25044350 |
CA |
21 | 2 |
Allergic transfusion reaction, Blood pressure systolic increased, Dyspnoea, Erythema, Feeling hot, Headache, Heart rate increased, Nausea, Respiratory rate increased, Somnolence, Transfusion reaction, Urticaria, |
||||
731 | 25044802 |
US |
14 | 2 |
Urticaria, Erythema, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
732 | 25044964 |
DK |
60 | 2 |
Muscle spasms, Peripheral motor neuropathy, Pain in extremity, Paraesthesia, Dysaesthesia, Muscular weakness, Peripheral sensory neuropathy, Hypoaesthesia, Back pain, Myalgia, Joint swelling, Tenderness, Peripheral swelling, Feeling hot, Erythema, Pruritus, Malaise, Rash, |
||||
LEFLUNOMIDE, LEFLUNOMIDE, INFLIXIMAB, |
||||
733 | 25045081 |
US |
20 | 2 |
Erythema, Skin burning sensation, Dry skin, |
||||
IXEKIZUMAB, DESONIDE, |
||||
734 | 25045351 |
FR |
74 | 2 |
Skin exfoliation, Erythema, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, FOSFOMYCIN TROMETHAMINE, GRANULES FOR ORAL SOLUTION, AMOXICILLIN, |
||||
735 | 25045451 |
US |
62 | 2 |
Erythema, Haemorrhage, Pruritus, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
736 | 25046191 |
CA |
71 | 2 |
Rectal haemorrhage, Vaginal discharge, Erythema, Anaemia, Chronic sinusitis, Colitis, Pyrexia, Therapeutic product effect incomplete, Nausea, Colitis ulcerative, Oral candidiasis, Constipation, Paraesthesia oral, Pain, Infusion related reaction, Procedural pain, Malaise, Abdominal pain, Headache, Weight decreased, Off label use, Vaginal flatulence, Radiculopathy, Drug ineffective, Female genital tract fistula, Frequent bowel movements, Macular degeneration, Dyspepsia, Haematochezia, Proctitis, |
||||
OXYBUTYNIN CHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, FLUTICASONE FUROATE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, HYDROCHLOROTHIAZIDE, PANTOPRAZOLE, FENTANYL, FENTANYL, DIPHENHYDRAMINE HYDROCHLORIDE, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, MESALAMINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CARBOXYMETHYLCELLULOSE SODIUM, ADALIMUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, MUPIROCIN, MUPIROCIN CALCIUM, MORPHINE SULFATE, PREDNISONE, NITROGLYCERIN, METRONIDAZOLE, METRONIDAZOLE TOPICAL, ERTAPENEM, ERTAPENEM SODIUM, DESONIDE, FLUTICASONE PROPIONATE, ZINC OXIDE, ZINC OXIDE OINTMENT, SKIN PROTECTANT, MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN, NICOTINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, VALSARTAN, GLYCERIN, GLYCERIN SUPPOSITORY, FLUTICASONE FUROATE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, NADOLOL, TRIMETHOPRIM, NICOTINAMIDE, PREGABALIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUCONAZOLE, INFLIXIMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CARBOXYMETHYLCELLULOSE SODIUM, VEDOLIZUMAB, VEDOLIZUMAB, HYDROMORPHONE HYDROCHLORIDE, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, MAGNESIUM OXIDE, CLARITHROMYCIN, GLYCERIN, GLYCERIN SUPPOSITORY, MAGNESIUM CARBONATE, HYDROCORTISONE, ALPRAZOLAM, FRUCTOSE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, |
||||
737 | 25046248 |
DE |
50 | 2 |
Anaphylactic shock, Hypotension, Tachycardia, Dyskinesia, Erythema, Body temperature increased, Breath sounds abnormal, |
||||
PROPOFOL, PROPOFOL, CEFUROXIME, SUFENTANIL, SUFENTANIL CITRATE, |
||||
738 | 25046432 |
US |
83 | 2 |
Injection site pain, Injection site paraesthesia, Injection site erythema, Injection site bruising, Diarrhoea, Insomnia, Injection site swelling, Injection site warmth, Pyrexia, Amenorrhoea, Erythema, Inflammation, |
||||
ANAKINRA, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, SERTRALINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
739 | 25046635 |
CN |
58 | 2 |
Anaphylactic shock, Head discomfort, Gait disturbance, Face oedema, Erythema, Blood pressure immeasurable, Oxygen saturation decreased, Depressed mood, Heart rate increased, Nausea, |
||||
IOPROMIDE, |
||||
740 | 25047041 |
FR |
83 | 2 |
Erythema, |
||||
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, LETROZOLE, LETROZOLE TABLETS, OXAZEPAM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, TELMISARTAN, HYDROCHLOROTHIAZIDE, |
||||
741 | 25047045 |
US |
80 | 2 |
Cervical spinal stenosis, Haemolysis, Neuropathy peripheral, Transient ischaemic attack, Sarcopenia, Iron metabolism disorder, Dry skin, Erythema, Ecchymosis, Raynaud^s phenomenon, Skin lesion, Livedo reticularis, Cardiac murmur, Varicose vein, Fatigue, Sleep disorder, Rhinorrhoea, Upper-airway cough syndrome, Dry mouth, Mouth ulceration, Dysphonia, Lymphadenopathy, Dysphagia, Skin hypopigmentation, Increased tendency to bruise, Alopecia, Temperature intolerance, Dry eye, Dyspnoea exertional, Constipation, Dyspepsia, Abdominal distension, Nocturia, Anxiety, Affect lability, Leukocytosis, Blood creatine phosphokinase decreased, Red blood cell sedimentation rate abnormal, Upper respiratory tract infection, Bronchospasm, |
||||
APREMILAST, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ETANERCEPT, MOMETASONE FUROATE, MAGNESIUM OXIDE, CELECOXIB, LORATADINE, LORATADINE ORAL, ABATACEPT, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LEVOTHYROXINE, ALBUTEROL SULFATE, ERGOCALCIFEROL, METHYLPREDNISOLONE, DICLOFENAC, DICLOFENAC SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, OXYCODONE, GABAPENTIN, AMOXICILLIN AND CLAVULANATE POTASSIUM, BACLOFEN, MONTELUKAST, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, EMPAGLIFLOZIN, LIRAGLUTIDE, LIRAGLUTIDE, DICLOFENAC SODIUM, COLCHICINE, PROPRANOLOL HYDROCHLORIDE, RIMEGEPANT SULFATE, UBROGEPANT, LEFLUNOMIDE, HYDROXYCHLOROQUINE SULFATE, AZATHIOPRINE, SULFASALAZINE, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, METHOTREXATE, TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION, |
||||
742 | 25047347 |
US |
||
Seizure, Respiratory arrest, Erythema, Feeling abnormal, Malaise, Decreased appetite, |
||||
PEGVALIASE-PQPZ, PEGVALIASE-PQPZ, |
||||
743 | 25047348 |
JP |
79 | 1 |
Pneumocystis jirovecii pneumonia, Pyrexia, Malignant neoplasm progression, Rash, Erythema, |
||||
PEMBROLIZUMAB, ENFORTUMAB VEDOTIN, |
||||
744 | 25047435 |
FR |
68 | 1 |
Erythema, Palmar erythema, Bronchospasm, Off label use, |
||||
PEMETREXED, PEMETREXED DISODIUM, CARBOPLATIN, AMIVANTAMAB, |
||||
745 | 25047447 |
GB |
52 | 2 |
Erythema, Dyspnoea, Malaise, Pain, |
||||
PACLITAXEL, |
||||
746 | 25047962 |
CO |
50 | 1 |
Limb injury, Erythema, Inflammation, Cellulitis, |
||||
RISANKIZUMAB-RZAA, |
||||
747 | 25038835 |
US |
72 | 2 |
Foot operation, Erythema, |
||||
IBRUTINIB, IBRUTINIB, |
||||
748 | 25038875 |
JP |
2 | |
Product dose omission in error, Injection site haemorrhage, Hallucination, visual, Erythema, Inappropriate schedule of product administration, |
||||
ABATACEPT, |
||||
749 | 25038952 |
CN |
33 | 2 |
Erythema multiforme, Rash, Skin temperature increased, Erythema, Pruritus, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
750 | 25039409 |
DE |
43 | 2 |
Anaphylactic shock, Burning sensation, Dyspnoea, Oral discomfort, Paraesthesia oral, Pruritus, Swelling, Swelling face, Erythema, |
||||
CEFUROXIME AXETIL, |
||||
751 | 25039443 |
US |
||
Haemorrhage urinary tract, Blood urine present, Abdominal pain, Erythema, Diarrhoea, Fatigue, |
||||
OSIMERTINIB, |
||||
752 | 25039599 |
CA |
34 | 1 |
Anxiety, Asthma, Bronchiectasis, Cystic fibrosis, Dyspnoea, Erythema, Eye oedema, Heat exhaustion, Histamine abnormal, Ill-defined disorder, Nightmare, Obstructive airways disorder, Off label use, Paranasal sinus discomfort, Pharyngeal swelling, Pruritus, Quality of life decreased, Rhinorrhoea, Swelling, Swelling of eyelid, Urticaria, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MONTELUKAST SODIUM, |
||||
753 | 25039969 |
GB |
58 | 2 |
Swelling face, Erythema, Facial pain, Rash, |
||||
DIMETHYL FUMARATE, |
||||
754 | 25040000 |
CA |
72 | 1 |
Burning sensation, Erythema, Flushing, Mental impairment, Pain, Pain in extremity, Paraesthesia, Pruritus, Rash, Rash erythematous, Skin plaque, Skin wound, Urticaria, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, RANITIDINE, |
||||
755 | 25040217 |
CA |
53 | 2 |
Abscess oral, Arrhythmia, Arthralgia, Asthma, Body temperature decreased, Cellulitis, Chest discomfort, Choking, Contusion, Cough, Discomfort, Drug hypersensitivity, Dyspnoea, Erythema, Fatigue, Fungal infection, Gingival pain, Hyperkeratosis, Hypersensitivity, Muscular weakness, Nasal congestion, Nausea, Oropharyngeal pain, Pain, Rhinorrhoea, Skin papilloma, Sneezing, Spirometry abnormal, Tachycardia, Tooth abscess, Vitamin D deficiency, Wheezing, Wrong technique in product usage process, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, NAPROXEN, NAPROXEN SODIUM, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CICLESONIDE, LANSOPRAZOLE, MONTELUKAST, MOMETASONE FUROATE, TIOTROPIUM BROMIDE, |
||||
756 | 25040231 |
CA |
29 | 2 |
Dyspnoea, Erythema, Face oedema, Illness, Incorrect dose administered, Influenza, Malaise, Multiple sclerosis, Pain, Pruritus, Pyrexia, Swelling face, Thalassaemia beta, Urticaria, Weight decreased, Inappropriate schedule of product administration, Product dose omission issue, Off label use, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, FLUOCINONIDE, FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%, MORPHINE, MONTELUKAST SODIUM, |
||||
757 | 25040252 |
CA |
76 | 2 |
Abdominal pain upper, Aphonia, Blood pressure systolic increased, Bronchitis, Burning sensation, Cough, Diarrhoea, Dyspepsia, Dysphonia, Dyspnoea, Erythema, Food poisoning, Foot deformity, Gastritis, Headache, Herpes zoster, Influenza, Laryngitis, Malaise, Nasopharyngitis, Oropharyngeal pain, Pain, Pharyngeal haemorrhage, Rhinorrhoea, Skin discolouration, Skin plaque, Vomiting, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
758 | 25040382 |
CA |
35 | 2 |
Urticaria, Abdominal pain, Appendicitis, Blood urine present, Cold urticaria, Erythema, Nasopharyngitis, Oral herpes, Paraesthesia, Sensation of foreign body, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MONTELUKAST SODIUM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, LORATADINE, LORATADINE TABLET, |
||||
759 | 25040474 |
CA |
71 | 2 |
Drug ineffective, Anaemia, Chronic sinusitis, Colitis, Colitis ulcerative, Therapeutic product effect incomplete, Female genital tract fistula, Frequent bowel movements, Haematochezia, Infusion related reaction, Macular degeneration, Off label use, Oral candidiasis, Pain, Procedural pain, Proctitis, Radiculopathy, Rectal haemorrhage, Vaginal discharge, Vaginal flatulence, Abdominal pain, Constipation, Dyspepsia, Erythema, Headache, Malaise, Nausea, Paraesthesia oral, Pyrexia, Weight decreased, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALPRAZOLAM, FLUTICASONE FUROATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FLUTICASONE FUROATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIPHENHYDRAMINE HYDROCHLORIDE, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CARBOXYMETHYLCELLULOSE SODIUM, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN HYDROCHLORIDE, CLARITHROMYCIN, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, HYDROCORTISONE, DESONIDE, HYDROMORPHONE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, VEDOLIZUMAB, VEDOLIZUMAB, ERTAPENEM, ERTAPENEM SODIUM, FENTANYL CITRATE, FLUTICASONE PROPIONATE, FLUCONAZOLE, FRUCTOSE, GLYCERIN, GLYCERIN SUPPOSITORY, GLYCERIN, GLYCERIN SUPPOSITORY, NITROGLYCERIN, ADALIMUMAB, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROMORPHONE HYDROCHLORIDE, INFLIXIMAB, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, MAGNESIUM CARBONATE, MAGNESIUM OXIDE, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MORPHINE SULFATE, MORPHINE SULFATE, MUPIROCIN, MUPIROCIN CALCIUM, NADOLOL, NICOTINE, NICOTINAMIDE, NICOTINE POLACRILEX, NICOITNE POLACRILEX, NICOTINE POLACRILEX GUM, NICOTINE, PANTOPRAZOLE, MESALAMINE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREDNISONE, PREGABALIN, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, CARBOXYMETHYLCELLULOSE SODIUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIMETHOPRIM, ZINC OXIDE, ZINC OXIDE OINTMENT, SKIN PROTECTANT, MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN, OXYBUTYNIN CHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, VALSARTAN, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, FENTANYL, |
||||
760 | 25040523 |
CA |
37 | 2 |
Blood pressure increased, Erythema, Feeling abnormal, Flushing, Inappropriate schedule of product administration, Nerve compression, Product dose omission issue, Pruritus, Rash erythematous, Self esteem inflated, Urticaria, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CROMOLYN SODIUM, CROMOLYN SODIUM, CROMOLYN SODIUM, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
761 | 25040530 |
CA |
1 | |
Spinal operation, Medical device removal, Infection, Sepsis, Erythema, Confusional state, Off label use, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, LEFLUNOMIDE, GABAPENTIN, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, METOPROLOL TARTRATE, METOPROLOL, PANTOPRAZOLE, GUSELKUMAB, ISOSORBIDE DINITRATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM CARBONATE, ANTACID, MAGNESIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
762 | 25040628 |
CA |
52 | 2 |
Abdominal pain, Arthralgia, Asthma, Blood pressure decreased, Coagulation time prolonged, Cough, Diarrhoea, Dizziness, Dyspnoea, Epistaxis, Erythema, Fatigue, Headache, Hot flush, Inflammation, Influenza like illness, Liver disorder, Nausea, Ocular discomfort, Oropharyngeal pain, Platelet count decreased, Product supply issue, Pruritus, Pyrexia, Rhinorrhoea, Seasonal allergy, Sinus congestion, Sinus disorder, Skin plaque, Urticaria, Viral infection, Vomiting, Weight decreased, Weight increased, Therapy partial responder, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DOXEPIN, DOXEPIN HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CYCLOBENZAPRINE, CYCLOBENZAPRINE, ERGOCALCIFEROL, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, RANITIDINE, RANITIDINE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
763 | 25040632 |
CA |
||
Cataract, Erythema, Pruritus, Rash, Off label use, Intentional product use issue, |
||||
RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
764 | 25040681 |
CA |
25 | 2 |
Accident, COVID-19, Erythema, Limb injury, Onychomycosis, Pain, Pain in extremity, Pruritus, Rash, Sleep disorder, Urticaria, Urticaria thermal, Visual impairment, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE, TERBINAFINE, |
||||
765 | 25040702 |
CN |
53 | 1 |
Drug eruption, Rash pruritic, Erythema, |
||||
OXALIPLATIN, PEMBROLIZUMAB, CAPECITABINE, LORATADINE, LORATADINE ORAL, |
||||
766 | 25041387 |
US |
62 | 2 |
Swelling face, Erythema, Feeling hot, Off label use, |
||||
767 | 25041419 |
IT |
55 | 1 |
Dyspnoea, Oropharyngeal swelling, Allergic oedema, Erythema, |
||||
INFLIXIMAB, |
||||
768 | 25041423 |
US |
72 | 2 |
Large intestinal stenosis, Weight decreased, Abdominal pain, Erythema, Fatigue, |
||||
DICLOFENAC, DICLOFENAC SODIUM, |
||||
769 | 25041529 |
ES |
58 | |
Erythema, Face oedema, Pruritus, Urticaria, Malaise, |
||||
ROSUVASTATIN, |
||||
770 | 25041540 |
IT |
57 | 1 |
Angioedema, Pruritus, Erythema, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
771 | 25041621 |
CA |
76 | 2 |
Abdominal pain, Chest pain, Diabetes mellitus, Drug ineffective, Erythema, Fungal infection, Nausea, Neck mass, Pain, Pruritus, Pyrexia, Rash, Rash erythematous, Therapeutic response shortened, Urinary tract infection, Urticaria, Vomiting, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, FLUCONAZOLE, PREDNISONE, PREDNISONE, |
||||
772 | 25041749 |
US |
28 | 1 |
Erythema, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, |
||||
773 | 25041793 |
US |
||
Erythema, Pruritus, |
||||
TIRZEPATIDE, |
||||
774 | 25041836 |
CA |
41 | 1 |
Abdominal pain upper, Depression, Erythema, Fatigue, Insomnia, Malaise, Urticaria, Pain, Renal disorder, Somnolence, Off label use, |
||||
OMALIZUMAB, OMALIZUMAB, DESOXIMETASONE, FLUTICASONE PROPIONATE, FINASTERIDE, ALBUTEROL SULFATE, |
||||
775 | 25041897 |
CA |
71 | 2 |
Abdominal pain, Anaemia, Chronic sinusitis, Colitis, Colitis ulcerative, Constipation, Drug ineffective, Dyspepsia, Erythema, Frequent bowel movements, Female genital tract fistula, Haematochezia, Headache, Infusion related reaction, Macular degeneration, Malaise, Nausea, Off label use, Oral candidiasis, Pain, Paraesthesia oral, Procedural pain, Proctitis, Pyrexia, Radiculopathy, Rectal haemorrhage, Therapeutic product effect incomplete, Vaginal discharge, Vaginal flatulence, Weight decreased, |
||||
HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, MORPHINE SULFATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALPRAZOLAM, FLUTICASONE FUROATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FLUTICASONE FUROATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIPHENHYDRAMINE HYDROCHLORIDE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CARBOXYMETHYLCELLULOSE SODIUM, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLARITHROMYCIN, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, HYDROCORTISONE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, VEDOLIZUMAB, VEDOLIZUMAB, ERTAPENEM, ERTAPENEM SODIUM, FENTANYL, FLUTICASONE PROPIONATE, FLUCONAZOLE, FRUCTOSE, GLYCERIN, GLYCERIN SUPPOSITORY, ADALIMUMAB, HYDROCHLOROTHIAZIDE, INFLIXIMAB, MAGNESIUM CARBONATE, MAGNESIUM OXIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, NADOLOL, NICOTINE, NICOTINAMIDE, PANTOPRAZOLE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREGABALIN, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, TRIMETHOPRIM, ZINC OXIDE, ZINC OXIDE OINTMENT, SKIN PROTECTANT, MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, OXYBUTYNIN CHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, VALSARTAN, |
||||
776 | 25041959 |
SK |
65 | 1 |
Erythema, Palpitations, |
||||
OXALIPLATIN, OXALIPLATIN, |
||||
777 | 25042110 |
BR |
46 | 2 |
Suicidal ideation, Psoriatic arthropathy, Skin discolouration, Weight increased, Heart rate increased, Stress, Pain of skin, Anxiety, Tremor, Skin exfoliation, Panic reaction, Chest discomfort, Nervousness, Social anxiety disorder, Skin fissures, Skin lesion, Binge eating, Burning sensation, Swelling, Discomfort, Pigmentation disorder, Erythema, Arthralgia, Psoriasis, Dyspnoea, Depression, Malaise, Chest pain, Pruritus, Therapeutic product effect incomplete, Drug ineffective, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
778 | 25042378 |
US |
27 | 1 |
Erythema, Pruritus, Off label use, |
||||
IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10%, IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10%, IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10%, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
779 | 25042436 |
CA |
||
Proctitis, Abdominal pain, Anaemia, Chronic sinusitis, Colitis, Colitis ulcerative, Constipation, Female genital tract fistula, Dyspepsia, Erythema, Weight decreased, Frequent bowel movements, Haematochezia, Headache, Infusion related reaction, Macular degeneration, Malaise, Nausea, Oral candidiasis, Pain, Paraesthesia oral, Procedural pain, Pyrexia, Radiculopathy, Rectal haemorrhage, Vaginal discharge, Vaginal flatulence, Drug ineffective, Off label use, Therapeutic product effect incomplete, |
||||
FLUTICASONE FUROATE, FLUTICASONE FUROATE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALPRAZOLAM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIPHENHYDRAMINE HYDROCHLORIDE, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CARBOXYMETHYLCELLULOSE SODIUM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN HYDROCHLORIDE, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, CLARITHROMYCIN, HYDROCORTISONE, DESONIDE, HYDROMORPHONE HYDROCHLORIDE, |
||||
780 | 25042532 |
CA |
||
Abdominal pain, Anaemia, Chronic sinusitis, Colitis, Colitis ulcerative, Constipation, Dyspepsia, Erythema, Female genital tract fistula, Frequent bowel movements, Haematochezia, Headache, Infusion related reaction, Macular degeneration, Malaise, Nausea, Oral candidiasis, Pain, Paraesthesia oral, Procedural pain, Pyrexia, Proctitis, Radiculopathy, Rectal haemorrhage, Vaginal discharge, Vaginal flatulence, Weight decreased, Drug ineffective, Therapeutic product effect incomplete, Off label use, |
||||
FLUTICASONE FUROATE, FLUTICASONE FUROATE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALPRAZOLAM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIPHENHYDRAMINE HYDROCHLORIDE, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLARITHROMYCIN, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, HYDROCORTISONE, DESONIDE, HYDROMORPHONE HYDROCHLORIDE, VEDOLIZUMAB, ERTAPENEM, ERTAPENEM SODIUM, |
||||
781 | 25042603 |
IL |
34 | 2 |
Asthenia, Hot flush, Erythema, Dyspnoea, Dizziness, Paraesthesia, |
||||
782 | 25042626 |
JP |
65 | 2 |
Cellulitis, Malignant neoplasm progression, Purulence, Pyrexia, Platelet count decreased, White blood cell count decreased, Erythema, |
||||
PEMBROLIZUMAB, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL, |
||||
783 | 25043036 |
US |
11 | 1 |
Respiratory syncytial virus infection, Sleep disorder due to a general medical condition, Erythema, Eczema, Pruritus, Skin fissures, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, |
||||
784 | 25043123 |
US |
82 | 1 |
Erythema, Adverse event, |
||||
DARATUMUMAB, TOCILIZUMAB, EPINASTINE HYDROCHLORIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
785 | 25043194 |
US |
1 | |
Erythema, |
||||
DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT), |
||||
786 | 25045874 |
66 | 2 | |
Anxiety, Cough, Oxygen saturation decreased, Erythema, Drug hypersensitivity, General physical health deterioration, |
||||
CEFTRIAXONE SODIUM, |
||||
787 | 25034066 |
PY |
33 | 2 |
Erythema, Arthritis, |
||||
TOCILIZUMAB, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, AZATHIOPRINE, LEFLUNOMIDE, HYDROXYCHLOROQUINE, |
||||
788 | 25034116 |
US |
2 | |
Erythema, Pruritus, Skin burning sensation, Product dose omission issue, |
||||
DUPILUMAB, |
||||
789 | 25034240 |
GB |
67 | 2 |
Palmar-plantar erythrodysaesthesia syndrome, Tenderness, Erythema, Burning sensation, Pain, Paraesthesia, Skin exfoliation, |
||||
CAPECITABINE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, BISOPROLOL FUMARATE, SIMVASTATIN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
790 | 25034250 |
US |
60 | |
Skin disorder, Pruritus, Skin discomfort, Dry skin, Depressed mood, Erythema, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
791 | 25034370 |
US |
1 | |
Erythema, Pruritus, Skin burning sensation, Off label use, |
||||
OMALIZUMAB, OMALIZUMAB, DUPILUMAB, |
||||
792 | 25034430 |
US |
45 | 2 |
Swelling of eyelid, Skin discolouration, Swelling face, Erythema, |
||||
AMOXICILLIN, IPTACOPAN, |
||||
793 | 25034471 |
PL |
2 | |
Malaise, Vomiting, Diarrhoea, Pain in extremity, Ecchymosis, Mobility decreased, Asthenia, Application site haemorrhage, C-reactive protein increased, Erythema, Flushing, |
||||
794 | 25034620 |
US |
||
Erythema, Hypersensitivity, Rash pruritic, |
||||
DAPAGLIFLOZIN, |
||||
795 | 25034661 |
US |
1 | |
Erythema, Urticaria, Pruritus, Drug ineffective, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, FAMOTIDINE, LORATADINE, LORATADINE ORAL, OMALIZUMAB, |
||||
796 | 25034919 |
US |
29 | 2 |
Hypersensitivity, Erythema, Urticaria, |
||||
797 | 25034996 |
ES |
||
Pruritus, Erythema, |
||||
VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, |
||||
798 | 25035084 |
US |
57 | 2 |
Erythema, Swelling, |
||||
TOCILIZUMAB, |
||||
799 | 25035102 |
DE |
1 | |
Multiple sclerosis relapse, Erythema, Influenza like illness, |
||||
DIMETHYL FUMARATE, OFATUMUMAB, |
||||
800 | 25035280 |
US |
||
Vomiting, Tremor, Palpitations, Hyperhidrosis, Nausea, Abdominal discomfort, Erythema, |
||||
DABIGATRAN ETEXILATE, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28